Mexico has a strong medicine manufacturing arm that supplies the entire country and exports to other parts of the Americas. About 95 percent of manufactured medicines are generics and can cost up to 80 percent less than their patented variant. However, these products represent only 53 percent of the medicine market’s value. Medicine production is expected to continue growing but as the public sector opens tenders to countries that do not have FTAs with Mexico and offer lower prices, manufacturers are looking to increase exports and sales to the private sector to continue growing.